Skin Graft
15
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts
PLASOMA Ultimate Safety & Efficacy Study
SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)
Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia
Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
PEP on a Skin Graft Donor Site Wound
Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery
Confirm the Safety and Performance of Avance Solo NPWT System
Autologous Adipose Stem Cell Assisted Skin Graft
Bioimpedance Based Monitoring of Operation Wound and Skin Graft Healing
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site
The Effects of Therapeutic Resources on Structure and Function of Normal and Burned Skin
Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing